Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

514 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Innate Immunity Activation in Newly Diagnosed Ileocolonic Crohn's Disease: A Cohort Study.
Angriman I, Bordignon G, Kotsafti A, Mescoli C, Scarpa M, Ruffolo C, Fassan M, Dei Tos AP, D'Incà R, Savarino EV, Zingone F, Pucciarelli S, Bardini R, Castagliuolo I, Scarpa M. Angriman I, et al. Among authors: dei tos ap. Dis Colon Rectum. 2024 May 1;67(5):681-692. doi: 10.1097/DCR.0000000000003145. Epub 2024 Feb 6. Dis Colon Rectum. 2024. PMID: 38319717
Impact of DNA mismatch repair proteins deficiency on number and ratio of lymph nodal metastases in colorectal adenocarcinoma.
Zannier F, Angerilli V, Spolverato G, Brignola S, Sandonà D, Balistreri M, Sabbadin M, Lonardi S, Bergamo F, Mescoli C, Scarpa M, Bao QR, Dei Tos AP, Pucciarelli S, Urso ELD, Fassan M. Zannier F, et al. Among authors: dei tos ap. Pathol Res Pract. 2023 Mar;243:154366. doi: 10.1016/j.prp.2023.154366. Epub 2023 Feb 10. Pathol Res Pract. 2023. PMID: 36774759 Free article.
PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2- BC patients with residual disease after neoadjuvant chemotherapy: a cohort study.
Miglietta F, Carraro V, Amato O, Griguolo G, Bottosso M, Munari G, Zarrilli G, Lo Mele M, Barbieri C, Dei Tos AP, Guarneri V, Dieci MV, Fassan M. Miglietta F, et al. Among authors: dei tos ap. J Clin Pathol. 2024 Sep 19;77(10):690-696. doi: 10.1136/jcp-2023-208856. J Clin Pathol. 2024. PMID: 37344170 Free PMC article.
MLH1 gene promoter methylation status partially overlaps with CpG methylator phenotype (CIMP) in colorectal adenocarcinoma.
Ceccon C, Borga C, Angerilli V, Bergamo F, Munari G, Sabbadin M, Gasparello J, Schiavi F, Zovato S, Scarpa M, Urso EDL, Dei Tos AP, Luchini C, Grillo F, Lonardi S, Parente P, Fassan M. Ceccon C, et al. Among authors: dei tos ap. Pathol Res Pract. 2024 Dec 21;266:155786. doi: 10.1016/j.prp.2024.155786. Online ahead of print. Pathol Res Pract. 2024. PMID: 39724851
Development of two machine learning models to predict conversion from primary HER2-0 breast cancer to HER2-low metastases: a proof-of-concept study.
Miglietta F, Collesei A, Vernieri C, Giarratano T, Giorgi CA, Girardi F, Griguolo G, Cacciatore M, Botticelli A, Vingiani A, Fotia G, Piacentini F, Massa D, Zanghì F, Marino M, Pruneri G, Fassan M, Dei Tos AP, Dieci MV, Guarneri V. Miglietta F, et al. Among authors: dei tos ap. ESMO Open. 2024 Dec 19;10(1):104087. doi: 10.1016/j.esmoop.2024.104087. Online ahead of print. ESMO Open. 2024. PMID: 39705838 Free PMC article.
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study.
Rebuzzi SE, Brunelli M, Galuppini F, Vellone VG, Signori A, Catalano F, Damassi A, Gaggero G, Rescigno P, Maruzzo M, Merler S, Vignani F, Cavo A, Basso U, Milella M, Panepinto O, Mencoboni M, Sbaraglia M, Dei Tos AP, Murianni V, Cremante M, Llaja Obispo MA, Maffezzoli M, Banna GL, Buti S, Fornarini G. Rebuzzi SE, et al. Among authors: dei tos ap. Cancers (Basel). 2023 Apr 21;15(8):2394. doi: 10.3390/cancers15082394. Cancers (Basel). 2023. PMID: 37190322 Free PMC article.
Predictors of Splenectomy Response in Immune Thrombocytopenia: A Multicentric Italian Study.
Zoletto S, Pizzi M, De Crescenzo A, Friziero A, D'Amore F, Carli G, Vianelli N, Auteri G, Bertozzi I, Nichele I, Binotto G, Dei Tos AP, Scarmozzino F, D'Amore ESG, Ceccato J, Sabattini E, Cinetto F, Piazza F, Visentin A, Zambello R, Trentin L, Vianello F. Zoletto S, et al. Among authors: dei tos ap. J Clin Med. 2024 Dec 25;14(1):30. doi: 10.3390/jcm14010030. J Clin Med. 2024. PMID: 39797114 Free PMC article.
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study).
Catalano F, Brunelli M, Signori A, Rescigno P, Buti S, Galli L, Spada M, Masini C, Galuppini F, Vellone VG, Gaggero G, Maruzzo M, Merler S, Vignani F, Cavo A, Bimbatti D, Milella M, Dei Tos AP, Sbaraglia M, Murianni V, Damassi A, Cremante M, Maffezzoli M, Llaja Obispo MA, Banna GL, Fornarini G, Rebuzzi SE. Catalano F, et al. Among authors: dei tos ap. Future Oncol. 2024 May 3:1-19. doi: 10.1080/14796694.2024.2340960. Online ahead of print. Future Oncol. 2024. PMID: 38861289
514 results